Nurix Therapeutics (NRIX) Insider Trading & Ownership

$24.74

-0.09 (-0.36%)

(As of 09/18/2024 ET)

Current Insider Ownership Percentage: 7.20%
Number Of Insiders Buying (Last 12 Months): 0
Number Of Insiders Selling (Last 12 Months): 3
Amount Of Insider Selling (Last 12 Months): $1.79 M

Get NRIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nurix Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NRIX Insider Buying and Selling by Quarter

Ad Porter & Company

The death of Nvidia?

Today, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S. housing… it's in artificial intelligence. And unless you know what’s really going on in this sector, you could be wiped out. You see, while there is no doubt that the recent advancements in artificial intelligence are game-changing and will drive colossal innovation in every sector of the economy... There's also no escaping that The Big AI Die-Up is coming.

So go here now to read my new report The Big AI Die-Up… while you still can.

Nurix Therapeutics Insider and Congressional Trades History

Transaction Type

Time Frame

Start Date

End Date

Export to Excel

Transaction Date	Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/3/2024	Christine Ring	Insider	Sell	9,050	$24.94	$225,707.00
8/26/2024	Christine Ring	Insider	Sell	9,870	$25.01	$246,848.70
8/26/2024	Houte Hans Van	CFO	Sell	20,000	$25.22	$504,400.00
8/1/2024	Christine Ring	Insider	Sell	5,760	$21.43	$123,436.80
8/1/2024	Houte Hans Van	CFO	Sell	3,477	$21.45	$74,581.65
7/30/2024	Gwenn Hansen	Insider	Sell	3,408	$20.67	$70,443.36
War on Elon Escalates… (Ad) A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth. One company holds a near-total monopoly on it.
7/30/2024	Houte Hans Van	CFO	Sell	2,490	$20.67	$51,468.30
7/1/2024	Christine Ring	Insider	Sell	5,760	$20.81	$119,865.60
6/12/2024	Christine Ring	Insider	Sell	1,900	$17.01	$32,319.00
6/5/2024	Christine Ring	Insider	Sell	400	$17.00	$6,800.00
6/3/2024	Christine Ring	Insider	Sell	1,596	$17.01	$27,147.96
5/2/2024	Houte Hans Van	CFO	Sell	3,499	$12.83	$44,892.17
4/30/2024	Gwenn Hansen	Insider	Sell	2,007	$12.04	$24,164.28
4/30/2024	Houte Hans Van	CFO	Sell	1,387	$12.04	$16,699.48
2/16/2024	Houte Hans Van	CFO	Sell	6,812	$10.02	$68,256.24
1/30/2024	Gwenn Hansen	Insider	Sell	2,334	$7.99	$18,648.66
1/30/2024	Houte Hans Van	CFO	Sell	1,671	$7.99	$13,351.29
12/19/2023	Houte Hans Van	CFO	Sell	10,906	$10.00	$109,060.00
10/31/2023	Christine Ring	Insider	Sell	1,232	$5.20	$6,406.40
10/31/2023	Houte Hans Van	CFO	Sell	1,080	$5.20	$5,616.00

(Data available from 1/1/2013 forward)

NRIX Insider Trading Activity - Frequently Asked Questions

: The list of insiders at Nurix Therapeutics includes Christine Ring, Gwenn Hansen, Houte Hans Van, and Stefani Wolff. Learn more on insiders at NRIX.
: 7.20% of Nurix Therapeutics stock is owned by insiders. Learn more on NRIX's insider holdings.
: The following insiders have sold NRIX shares in the last 24 months: Christine Ring ($827,965.18), Gwenn Hansen ($174,299.14), Houte Hans Van ($927,865.90), and Stefani Wolff ($12,881.68).
: Insiders have sold a total of 108,630 Nurix Therapeutics shares in the last 24 months for a total of $1,943,011.90 sold.